AXQ Capital
EDIT icon

AXQ Capital’s Editas Medicine EDIT Stock Holding History

AXQ Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$80.5K Sell
31,311
-5,141
-14% -$15.1K 0.01% 915
2026
Q2 		$118K Buy
+36,452
New +$107K 0.01% 807
2025
Q3 		– Sell
-47,083
Closed -$104K – 647
2025
Q2 		$104K Buy
+47,083
New +$77K 0.03% 516
2023
Q3 		– Sell
-10,072
Closed -$82.9K – 508
2023
Q2 		$82.9K Buy
+10,072
New +$87.7K 0.1% 249
2023
Q1 		– Sell
-20,801
Closed -$185K – 516
2022
Q4 		$185K Buy
+20,801
New +$228K 0.13% 275

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

AXQ Capital's EDIT Position: Q3 2026 in Review

AXQ Capital reduced its Editas Medicine (EDIT) stake by 14% in Q3 2026, selling an estimated $15.1K and leaving 31,311 shares worth $80.5K. The position accounts for 0.01% of the portfolio, ranked #915.

AXQ Capital first reported a position in EDIT in Q4 2022 and has held it in 5 quarters since. The position peaked at $185K in Q4 2022. 119 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • AXQ Capital held 31,311 shares of Editas Medicine worth $80.5K as of Q3 2026.
  • AXQ Capital sold 5,141 Editas Medicine shares in Q3 2026, an estimated $15.1K.
  • Editas Medicine made up 0.01% of AXQ Capital's portfolio in Q3 2026, its #915 holding.
  • AXQ Capital first reported a position in Editas Medicine in Q4 2022 and has held it in 5 quarters since.
  • AXQ Capital's Editas Medicine position peaked at $185K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.